Mitochondria regulate cardiac contraction through ATP-dependent and independent mechanisms

References

• Brookes PS, Yoon Y, Robotham JL, et al. Calcium, ATP, and ROS: a mitochondrial love–hate triangle. Am J Physiol Cell Physiol. 2004;287(4):C817–C833.
   PubMed Web of Science ®Google Scholar
• Divakaruni AS, Murphy AN. Cell biology. A mitochondrial mystery, solved. Science. 2012;337(6090):41–43.
   PubMed Web of Science ®Google Scholar
• Tarasov AI, Griffiths EJ, Rutter GA. Regulation of ATP production by mitochondrial Ca(2+). Cell Calcium. 2012;52(1):28–35.
   PubMed Web of Science ®Google Scholar
• Kamer KJ, Mootha VK. MICU1 and MICU2 play nonredundant roles in the regulation of the mitochondrial calcium uniporter. EMBO Rep. 2014;15(3):299–307.
   PubMed Web of Science ®Google Scholar
• Williams GS, Boyman L, Chikando AC, et al. Mitochondrial calcium uptake. Proc Natl Acad Sci USA. 2013;110(26):10479–10486.
   PubMed Web of Science ®Google Scholar
• Tota B, Cerra MC, Handy RD. Radical species, mitochondria and cardiac function. Biochim Biophys Acta. 2009;1787(7):773.
   PubMed Web of Science ®Google Scholar
• Kang J, Pervaiz S. Mitochondria: redox metabolism and dysfunction. Biochem Res Int. 2012;2012:896751.
   PubMedGoogle Scholar
• Taegtmeyer H, Wilson CR, Razeghi P, et al. Metabolic energetics and genetics in the heart. Ann N Y Acad Sci. 2005;1047:208–218.
   PubMed Web of Science ®Google Scholar
• Ashrafian H, Frenneaux MP. Metabolic modulation in heart failure: the coming of age. Cardiovasc Drugs Ther. 2007;21(1):5–7.
   PubMed Web of Science ®Google Scholar
• Drenckhahn JD. Heart development: mitochondria in command of cardiomyocyte differentiation. Dev Cell. 2011;21(3):392–393.
   PubMed Web of Science ®Google Scholar
• Neubauer S. The failing heart – an engine out of fuel. N Engl J Med. 2007;356(11):1140–1151.
   PubMed Web of Science ®Google Scholar
• Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999;283(5407):1482–1488.
   PubMed Web of Science ®Google Scholar
• Meyers DE, Basha HI, Koenig MK. Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management. Tex Heart Inst J. 2013;40(4):385–394.
   PubMed Web of Science ®Google Scholar
• Rosenberg PB. Mitochondrial dysfunction and heart disease. Mitochondrion. 2004;4(5–6):621–628.
   PubMed Web of Science ®Google Scholar
• Verma SK, Garikipati VNS, Kishore R. Mitochondrial dysfunction and its impact on diabetic heart. Biochim Biophys Acta. 2017;1863(5):1098–1105.
   PubMed Web of Science ®Google Scholar
• Fillmore N, Mori J, Lopaschuk GD. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy. Br J Pharmacol. 2014;171(8):2080–2090.
   PubMed Web of Science ®Google Scholar
• Huss JM, Kelly DP. Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest. 2005;115(3):547–555.
   PubMed Web of Science ®Google Scholar
• Larsson NG, Rustin P. Animal models for respiratory chain disease. Trends Mol Med. 2001;7(12):578–581.
   PubMed Web of Science ®Google Scholar
• Sripetchwandee J, Kenknight SB, Sanit J, et al. Blockade of mitochondrial calcium uniporter prevents cardiac mitochondrial dysfunction caused by iron overload. Acta Physiol. 2014;210(2):330–341.
   PubMed Web of Science ®Google Scholar
• Finsterer J, Kothari S. Cardiac manifestations of primary mitochondrial disorders. Int J Cardiol. 2014;177(3):754–763.
   PubMed Web of Science ®Google Scholar
• Rosca MG, Hoppel CL. Mitochondria in heart failure. Cardiovasc Res. 2010;88(1):40–50.
   PubMed Web of Science ®Google Scholar
• Alvarado G, Jeney V, Tóth A, et al. Heme-induced contractile dysfunction in Human cardiomyocytes caused by oxidant damage to thick filament proteins. Free Radic Biol Med. 2015;89:248–262.
   PubMed Web of Science ®Google Scholar
• Haack TB, Kopajtich R, Freisinger P, et al. ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy. Am J Hum Genet. 2013;93(2):211–223.
   PubMed Web of Science ®Google Scholar
• Cortassa S, O’Rourke B, Winslow RL, et al. Control and regulation of mitochondrial energetics in an integrated model of cardiomyocyte function. Biophys J. 2009;96(6):2466–2478.
   PubMed Web of Science ®Google Scholar
• Chouchani ET, Methner C, Buonincontri G, et al. Complex I deficiency due to selective loss of Ndufs4 in the mouse heart results in severe hypertrophic cardiomyopathy. PLoS One. 2014;9(4):e94157.
   PubMed Web of Science ®Google Scholar
• Raval KK, Kamp TJ. Cardiomyopathy, mitochondria and Barth syndrome: iPSCs reveal a connection. Nat Med. 2014;20(6):585–586.
   PubMed Web of Science ®Google Scholar
• Fieni F, Johnson DE, Hudmon A, et al. Mitochondrial Ca2+ Uniporter and CaMKII in heart. Nature. 2014;513(7519):E1–E2.
   PubMed Web of Science ®Google Scholar
• Lim HY, Wang W, Chen J, et al. ROS regulate cardiac function via a distinct paracrine mechanism. Cell Rep. 2014;7(1):35–44.
   PubMed Web of Science ®Google Scholar
• Nakayama H, Chen X, Baines CP, et al. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest. 2007;117(9):2431–2444.
   PubMed Web of Science ®Google Scholar
• Antoons G, Ver Heyen MV, Raeymaekers L, et al. Ca2+ uptake by the sarcoplasmic reticulum in ventricular myocytes of the SERCA2b/b mouse is impaired at higher Ca2+ loads only. Circ Res. 2003;92(8):881–887.
   PubMed Web of Science ®Google Scholar
• Hurtley SM. A change of heart (mitochondria). Sci Signal. 2015;8(406):ec367–ec367.
   Google Scholar
• Ross J, Sobel BE. Regulation of cardiac contraction. Annu Rev Physiol. 1972;34:47–90.
   PubMed Web of Science ®Google Scholar
• Ingwall JS. Energy metabolism in heart failure and remodelling. Cardiovasc Res. 2009;81(3):412–419.
   PubMed Web of Science ®Google Scholar
• Morimoto S. Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res. 2008;77(4):659–666.
   PubMed Web of Science ®Google Scholar
• Lu QW, Wu XY, Morimoto S. Inherited cardiomyopathies caused by troponin mutations. J Geriatr Cardiol. 2013;10(1):91–101.
   PubMedGoogle Scholar
• Picard M, Hepple RT, Burelle Y. Mitochondrial functional specialization in glycolytic and oxidative muscle fibers: tailoring the organelle for optimal function. Am J Physiol Cell Physiol. 2012;302(4):C629–C641.
   PubMed Web of Science ®Google Scholar
• Ding J, Chen J, Wang Y, et al. Trbp regulates heart function through microRNA-mediated Sox6 repression. Nat Genet. 2015;47(7):776–783.
   PubMed Web of Science ®Google Scholar
• Kolwicz SC, Purohit S, Tian R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res. 2013;113(5):603–616.
   PubMed Web of Science ®Google Scholar
• Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85(3):1093–1129.
   PubMed Web of Science ®Google Scholar
• Prosdocimo DA, Anand P, Liao X, et al. Kruppel-like factor 15 is a critical regulator of cardiac lipid metabolism. J Biol Chem. 2014;289(9):5914–5924.
   PubMed Web of Science ®Google Scholar
• Kapelko VI, Kupriyanov VV, Novikova NA, et al. The cardiac contractile failure induced by chronic creatine and phosphocreatine deficiency. J Mol Cell Cardiol. 1988;20(6):465–479.
   PubMed Web of Science ®Google Scholar
• Aksentijević D, Mcandrew DJ, Karlstädt A, et al. Cardiac dysfunction and periweaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity. J Mol Cell Cardiol. 2014;75:76–87.
   PubMed Web of Science ®Google Scholar
• Abel ED, Kaulbach HC, Tian R, et al. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest. 1999;104(12):1703–1714.
   PubMed Web of Science ®Google Scholar
• Kolwicz SC, Olson DP, Marney LC, et al. Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy. Circ Res. 2012;111(6):728–738.
   PubMed Web of Science ®Google Scholar
• Liao R, Nascimben L, Friedrich J, et al. Decreased energy reserve in an animal model of dilated cardiomyopathy relationship to contractile performance. Circ Res. 1996;78(5):893–902.
   PubMed Web of Science ®Google Scholar
• Tian R, Nascimben L, Ingwall JS, et al. Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts. Circulation. 1997;96(4):1313–1319.
   PubMed Web of Science ®Google Scholar
• Matalon R, Michaels K, Kaul R, et al. Malonic aciduria and cardiomyopathy. J Inherit Metab Dis. 1993;16(3):571–573.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick DR, Hill A, Tolmie JL, et al. The molecular basis of malonyl-CoA decarboxylase deficiency. Am J Hum Genet. 1999;65(2):318–326.
   PubMed Web of Science ®Google Scholar
• Graham BH, Waymire KG, Cottrell BA, et al. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet. 1997;16(3):226–234.
   PubMed Web of Science ®Google Scholar
• Huss JM, Kelly DP. Nuclear receptor signaling and cardiac energetics. Circ Res. 2004;95(6):568–578.
   PubMed Web of Science ®Google Scholar
• Kumar A, Kaur H, Devi P, et al. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacol Ther. 2009;124(3):259–268.
   PubMed Web of Science ®Google Scholar
• Prosdocimo DA, John JE, Zhang L, et al. KLF15 and PPARα cooperate to regulate cardiomyocyte lipid gene expression and oxidation. PPAR Res. 2015;2015:201625.
   PubMedGoogle Scholar
• Luptak I, Balschi JA, Xing Y, et al. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-α–null hearts can be rescued by increasing glucose transport and utilization. Circulation. 2005;112(15):2339–2346.
   PubMed Web of Science ®Google Scholar
• Arany Z, He H, Lin J, et al. Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle. Cell Metab. 2005;1(4):259–271.
   PubMed Web of Science ®Google Scholar
• Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1(1):11–21.
   PubMed Web of Science ®Google Scholar
• Ringer S. A further contribution regarding the influence of the different constituents of the blood on the contraction of the heart. J Physiol. 1883;4(1):29–42.3.
   PubMedGoogle Scholar
• Bers DM. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res. 2000;87(4):275–281.
   PubMed Web of Science ®Google Scholar
• Bodi I, Mikala G, Koch SE, et al. The L-type calcium channel in the heart: the beat goes on. J Clin Invest. 2005;115(12):3306–3317.
   PubMed Web of Science ®Google Scholar
• Jaleel N, Nakayama H, Chen X, et al. Ca2+ influx through T- and L-type Ca2+ channels have different effects on myocyte contractility and induce unique cardiac phenotypes. Circ Res. 2008;103(10):1109–1119.
   PubMed Web of Science ®Google Scholar
• Balderas-Villalobos J, Molina-Muñoz T, Mailloux-Salinas P, et al. Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome. Am J Physiol Heart Circ Physiol. 2013;305(9):H1344–H1353.
   PubMed Web of Science ®Google Scholar
• Park WJ, Oh JG. SERCA2a: a prime target for modulation of cardiac contractility during heart failure. BMB Rep. 2013;46(5):237–243.
   PubMed Web of Science ®Google Scholar
• Prasad V, Okunade GW, Miller ML, et al. Phenotypes of SERCA and PMCA knockout mice. Biochem Biophys Res Commun. 2004;322(4):1192–1203.
   PubMed Web of Science ®Google Scholar
• Sugamura K, Keaney JF. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med. 2011;51(5):978–992.
   PubMed Web of Science ®Google Scholar
• Prosser BL, Khairallah RJ, Ziman AP, et al. X-ROS signaling in the heart and skeletal muscle: stretch-dependent local ROS regulates [Ca2+] i. J Mol Cell Cardiol. 2013;58:172–181.
   PubMed Web of Science ®Google Scholar
• Prosser BL, Ward CW, Lederer WJ. X-ROS signalling is enhanced and graded by cyclic cardiomyocyte stretch. Cardiovasc Res. 2013;98(2):307–314.
   PubMed Web of Science ®Google Scholar
• Sánchez G, Pedrozo Z, Domenech RJ, et al. Tachycardia increases NADPH oxidase activity and RyR2 S-glutathionylation in ventricular muscle. J Mol Cell Cardiol. 2005;39(6):982–991.
   PubMed Web of Science ®Google Scholar
• Chen FC, Ogut O. Decline of contractility during ischemia-reperfusion injury: actin glutathionylation and its effect on allosteric interaction with tropomyosin. Am J Physiol Cell Physiol. 2006;290(3):C719–C727.
   PubMed Web of Science ®Google Scholar
• Canton M, Neverova I, Menabò R, et al. Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts. Am J Physiol Heart Circ Physiol. 2004;286(3):H870–H877.
   PubMed Web of Science ®Google Scholar
• Melov S, Coskun PE, Wallace DC. Mouse models of mitochondrial disease, oxidative stress, and senescence. Mutat Res. 1999;434(3):233–242.
   PubMedGoogle Scholar
• Canton M, Menazza S, Sheeran FL, et al. Oxidation of myofibrillar proteins in human heart failure. J Am Coll Cardiol. 2011;57(3):300–309.
   PubMed Web of Science ®Google Scholar
• Steinberg SF. Oxidative stress and sarcomeric proteins. Circ Res. 2013;112(2):393–405.
   PubMed Web of Science ®Google Scholar
• Hansson A, Hance N, Dufour E, et al. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci U S A. 2004;101(9):3136–3141.
   PubMed Web of Science ®Google Scholar
• Sánchez JA, García MC, Sharma VK, et al. Mitochondria regulate inactivation of L-type Ca2+ channels in rat heart. J Physiol. 2001;536(2):387–396.
   PubMed Web of Science ®Google Scholar
• Drago I, De Stefani D, Rizzuto R, et al. Mitochondrial Ca2+ uptake contributes to buffering cytoplasmic Ca2+ peaks in cardiomyocytes. Proc Natl Acad Sci U S A. 2012;109(32):12986–12991.
   PubMed Web of Science ®Google Scholar
• Kirichok Y, Krapivinsky G, Clapham DE. The mitochondrial calcium uniporter is a highly selective ion channel. Nature. 2004;427(6972):360–364.
   PubMed Web of Science ®Google Scholar
• Bick AG, Wakimoto H, Kamer KJ, et al. Cardiovascular homeostasis dependence on MICU2, a regulatory subunit of the mitochondrial calcium uniporter. Proc Natl Acad Sci U S A. 2017;114(43):E9096–E9104.
   PubMed Web of Science ®Google Scholar
• Brown GC, Borutaite V. There is no evidence that mitochondria are the main source of reactive oxygen species in mammalian cells. Mitochondrion. 2012;12(1):1–4.
   PubMed Web of Science ®Google Scholar
• Chen YR, Zweier JL. Cardiac mitochondria and reactive oxygen species generation. Circ Res. 2014;114(3):524–537.
   PubMed Web of Science ®Google Scholar
• Zhang D, Li Y, Heims-Waldron DA, et al. Mitochondrial cardiomyopathy caused by elevated reactive oxygen species and impaired cardiomyocyte proliferation. Circ Res. 2018;122(1):74–87.
   PubMed Web of Science ®Google Scholar
• Hammerling BC, Gustafsson ÅB. Mitochondrial quality control in the myocardium: cooperation between protein degradation and mitophagy. J Mol Cell Cardiol. 2014;75:122–130.
   PubMed Web of Science ®Google Scholar
• Moore AS, Wong YC, Simpson CL, et al. Dynamic actin cycling through mitochondrial subpopulations locally regulates the fission–fusion balance within mitochondrial networks. Nat Commun. 2016;7:12886.
   PubMed Web of Science ®Google Scholar
• Leites EP, Morais VA. Mitochondrial quality control pathways: PINK1 acts as a gatekeeper. Biochem Biophys Res Commun. 2017;17:S0006–S291X.
   Google Scholar
• Song M, Franco A, Fleischer JA, et al. Abrogating mitochondrial dynamics in mouse hearts accelerates mitochondrial senescence. Cell Metab. 2017;26(6):872–883.e5.
   PubMed Web of Science ®Google Scholar
• Song M, Mihara K, Chen Y, et al. Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts. Cell Metab. 2015;21(2):273–286.
   PubMed Web of Science ®Google Scholar
• Eisner V, Cupo RR, Gao E, et al. Mitochondrial fusion dynamics is robust in the heart and depends on calcium oscillations and contractile activity. Proc Natl Acad Sci U S A. 2017;114(5):E859–E868.
   PubMed Web of Science ®Google Scholar
• Otera H, Wang C, Cleland MM, et al. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol. 2010;191(6):1141–1158.
   PubMed Web of Science ®Google Scholar
• Kageyama Y, Hoshijima M, Seo K, et al. Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain. EMBO J. 2014;33(23):2798–2813.
   PubMed Web of Science ®Google Scholar
• Ishihara T, Ban-Ishihara R, Maeda M, et al. Dynamics of mitochondrial DNA nucleoids regulated by mitochondrial fission is essential for maintenance of homogeneously active mitochondria during neonatal heart development. Mol Cell Biol. 2015;35(1):211–223.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu Y, Dorn GW. Mitochondrial fusion is essential for organelle function and cardiac homeostasis novelty and significance. Circ Res. 2011;109(12):1327–1331.
   PubMed Web of Science ®Google Scholar
• Papanicolaou KN, Kikuchi R, Ngoh GA, et al. Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart. Circ Res. 2012;111(8):1012–1026.
   PubMed Web of Science ®Google Scholar
• Kasahara A, Cipolat S, Chen Y, et al. Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling. Science. 2013;342(6159):734–737.
   PubMed Web of Science ®Google Scholar
• Camello-Almaraz C, Gomez-Pinilla PJ, Pozo MJ, et al. Mitochondrial reactive oxygen species and Ca2+ signaling. Am J Physiol Cell Physiol. 2006;291(5):C1082–C1088.
   PubMed Web of Science ®Google Scholar
• Akaike T, Ida T, Wei FY, et al. Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics. Nat Commun. 2017;8(1):1177.
   PubMedGoogle Scholar
• Foster DW. Malonyl-CoA: the regulator of fatty acid synthesis and oxidation. J Clin Invest. 2012;122(6):1958–1959.
   PubMed Web of Science ®Google Scholar
• Celato A, Mitola C, Tolve M, et al. A new case of malonic aciduria with a presymptomatic diagnosis and an early treatment. Brain Dev. 2013;35(7):675–680.
   PubMed Web of Science ®Google Scholar
• Lake NJ, Compton AG, Rahman S, et al. Leigh syndrome: one disorder, more than 75 monogenic causes. Ann Neurol. 2016;79(2):190–203.
   PubMed Web of Science ®Google Scholar
• Hoefs SJG, Van Spronsen FJ, Lenssen EWH, et al. NDUFA10 mutations cause complex I deficiency in a patient with Leigh disease. Eur J Hum Genet. 2011;19(3):270–274.
   PubMed Web of Science ®Google Scholar
• Bénit P, Slama A, Cartault F, et al. Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome. J Med Genet. 2004;41(1):14–17.
   PubMed Web of Science ®Google Scholar
• Leshinsky-Silver E, Lebre AS, Minai L, et al. NDUFS4 mutations cause Leigh syndrome with predominant brainstem involvement. Mol Genet Metab. 2009;97(3):185–189.
   PubMed Web of Science ®Google Scholar
• Bénit P, Beugnot R, Chretien D, et al. Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy. Hum Mutat. 2003;21(6):582–586.
   PubMed Web of Science ®Google Scholar
• Loeffen JLCM, Elpeleg O, Smeitink JAM, et al. Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol. 2001;49(2):195–201.
   PubMed Web of Science ®Google Scholar
• Kruse SE, Watt WC, Marcinek DJ, et al. Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. Cell Metab. 2008;7(4):312–320.
   PubMed Web of Science ®Google Scholar
• Ingraham CA, Burwell LS, Skalska J, et al. NDUFS4: creation of a mouse model mimicking a complex I disorder. Mitochondrion. 2009;9(3):204–210.
   PubMed Web of Science ®Google Scholar
• Johnson SC, Yanos ME, Kayser EB, et al. mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science. 2013;342(6165):1524–1528.
   PubMed Web of Science ®Google Scholar
• Jain IH, Zazzeron L, Goli R, et al. Hypoxia as a therapy for mitochondrial disease. Science. 2016;352(6281):54–61.
   PubMed Web of Science ®Google Scholar
• Steward CG, Newbury-Ecob RA, Hastings R, et al. Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth. Prenat Diagn. 2010;30(10):970–976.
   PubMed Web of Science ®Google Scholar
• Schlame M, Ren M. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett. 2006;580(23):5450–5455.
   PubMed Web of Science ®Google Scholar
• Wang G, Mccain ML, Yang L, et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat Med. 2014;20(6):616–623.
   PubMed Web of Science ®Google Scholar
• Zweigerdt R, Gruh I, Martin U. Your heart on a chip: iPSC-based modeling of Barth-syndrome-associated cardiomyopathy. Cell Stem Cell. 2014;15(1):9–11.
   PubMed Web of Science ®Google Scholar